1/9/2013

BioPhotas has secured FDA clearance to market its Celluma biophotonic device, which treats muscle, joint and skin conditions using three different light wavelengths. The device has been cleared for use in patients with compromised local blood flow, muscle spasms and four other conditions.

Full Story:
BeckersASC.com

Related Summaries